LUNG Stock Analysis: Buy, Sell, or Hold?
LUNG - Pulmonx Corporation Common Stock
$1.33
0.05 (3.91%)
▲
5d:
+7.26%
30d:
-7.64%
90d:
-39.82%
BUY
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: Apr 29, 2026
23d
Smart Money Accumulation
LUNG is down 19.1% this week, but smart money is accumulating calls. Top strike: $2 2026-05-15 with 62 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When LUNG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: LUNG shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: LUNG shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: LUNG is currently trading at $1.33, which is considered slightly low relative to its 30-day fair value range of $1.29 to $1.73.
Technical Outlook: Technically, LUNG is in a downtrend. Immediate support is located at $1.13, while resistance sits at $1.45. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: LUNG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.17 (+288.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, LUNG is in a downtrend. Immediate support is located at $1.13, while resistance sits at $1.45. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: LUNG has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $5.17 (+288.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.29 -
$1.73
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading 288.5% below Wall St target ($5.17)
Fair Price Analysis
30-Day Fair Range
$1.29 -
$1.73
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$0.21
(16.2%)
Support & Resistance Levels
Support Level
$1.13
Resistance Level
$1.45
Current Trend
Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.32
Wall Street Target
$5.17
(+288.5%)
Revenue Growth (YoY)
-4.9%
Profit Margin
-59.7%
Share & Embed Analysis
Last updated: April 05, 2026 1:30 PM ET
Data refreshes hourly during market hours. Next update: 2:30 PM
Data refreshes hourly during market hours. Next update: 2:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LUNG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Geoffrey Beran Rose
SELL
7732 shares
2026-03-02
Glendon E French III
SELL
67813 shares
2026-03-02
Srikanth Radhakrishnan
SELL
10483 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$102 | 60 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$86 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$354 | 52 HOLD |
